Performance funds/ETFs
UBS | UBS Biotechnology USD Acc
The fund primarily invests globally in equities of companies with a connection to the biotechnology sector. Working on the basis of well-grounded analyses by our investment specialists worldwide, the fund manager combines carefully selected equities of various companies from various countries and segments with the objective of exploiting interesting earnings opportunities while keeping the level of risk under control.
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
$408,22
Quote date
31-03-2026
Performance in EUR
Date
31-03-2026
This year
4,10%
1 week
5,08%
1 month
-1,84%
3 months
4,10%
6 months
20,20%
1 year
35,90%
3 years (annualised)
9,01%
5 years (annualised)
5,01%
Since start (annualised)
8,62%
Indicators
Standard deviation (3yr)
19,00%
Share ratio (3yr)
0,39
Beta (3yr)
0,87
Alpha (3yr)
4,89
Tracking error (3yr)
14,04
Top 10 holdings
Fees
Entry fee
0,60%
Exit charges
0,60%
Estimated ongoing charges
1,10%
Dividend
Dividend paying
No
Characteristic
Asset Manager
UBS
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Active
Fund code
54419
Fund code fractional orders
54419
Fund manager name
Matthew Konosky|Pascal Mercier|Sarah Schram
ISIN
LU0400035332
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Luxembourg
Currency
USD
Fund size (mio)
$381,71 (30-03-2026)
Cut-off time
11:00:00
Execution date
Yes, T+1
Inception date
12-11-2012
Benchmark
MSCI US IMI/BIOTECHNOLOGY 10/40 NR USD
Minimum investment amount
€20
Assortiment
Self Directed Investing Plus, Investment advice